Thursday 09 Jan, 2025 07:21 AM
Site map | Locate Us | Login
   Transformers & Rectifiers hits life high as Q3 PAT zooms to Rs 55 cr; board OKs 1:1 bonus issue    Prime Focus gains after arm incorporates new subsidiary    One 97 Communications Ltd leads losers in 'A' group    United Breweries drops after halting beer supply to TGBCL    Bharat Immunological & Biological Corporation Ltd leads losers in 'B' group    Suven Life spurts on initiating Phase-1 of clinical trial in US    Volumes jump at MMTC Ltd counter    Waaree Renewable Tech slips after CFO Dilip Panjwani resigns    Industrials stocks slide    Power shares slide    Consumer Durables shares fall    Visaka Industries spurts after Co's solar roofing product receives ALMM Certification    Aurobindo Pharma Ltd slips for fifth straight session    JSW Energy Ltd drops for fifth straight session    Hitachi Energy India Ltd drops for fifth straight session 
Saravan Stocks
  BSE     NSE
Company News
Sai Life Sciences Ltd
Sai Life Sciences spurts on debut
Dec 18,2024   Hrs IST

The scrip was listed at Rs 660, exhibiting a premium of 20.22% to the issue price.

So far, the stock has hit a high of 675 and a low of 651.20. On the BSE, over 7.98 lakh shares of the company were traded in the counter so far.

The initial public offer (IPO) of Sai Life Sciences was subscribed 10.26 times. The issue opened for bidding on Wednesday (11 December 2024) and it closed on Friday (13 December 2024). The price band of the IPO is fixed at Rs 522–549 per share.

The IPO comprised a fresh issue of equity shares worth up to Rs 950 crore and an offer for sale of 3,81,16,934 equity shares aggregating up to Rs 2,092.62 crore by existing shareholders.

The promoters and promoter group hold an aggregate of 41.82% of the pre-offer issued and paid-up equity share capital. Their post-IPO shareholding is expected to be around 35.24%.

Out of the proceeds from the fresh issue, Rs 720 crore will be used for the repayment/prepayment of all or certain outstanding borrowings, with the remaining amount allocated for general corporate purposes.

Ahead of the IPO, Sai Life Sciences on Tuesday, 10 December 2024 raised Rs 912.78 crore from anchor investors. The board allotted 1.66 crore shares at Rs 549 each to 63 anchor investors.

Sai Life Sciences is an innovator-focused contract research, development, and manufacturing organization (CRDMO). It provides end-to-end services across the drug discovery, development, and manufacturing value chain for small-molecule new chemical entities (NCE) to global pharmaceutical innovator companies and biotechnology firms.

The company reported a consolidated net profit of Rs 28.01 crore and net sales of Rs 675.29 crore for the six months ended on 30 September 2024.

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 38079610
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd